BioSpace News Archive

Mirion Technologies, Inc. today announced that it had completed the acquisition of Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.

EQRx today announced that the U.S. Securities and Exchange Commission (“SEC”) has declared CM Life Sciences III’s registration statement on Form S-4 relating to the previously announced business combination agreement between EQRx and CM Life Sciences III effective.

Aurora Spine Corporation today announced it has retained PRIA Healthcare to assist in patient access for its proprietary products, including ZIP® and SiLO.

Shattuck Labs, Inc. today announced its presentation at the TIGIT Therapies Digital Summit 2021 being held virtually December 7 – 9, 2021.

Plus Therapeutics, Inc. today announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will present a company overview during the MedInvest Oncology Investor Conference on Tuesday, December 7th at 12:00 p.m. ET.

Xilio Therapeutics, Inc. today reported recent pipeline and business progress and third quarter 2021 financial results.

Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva ® CTD Essential Reagent for use on the Aptiva ® system.

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced that the Company granted stock options to two new employees to purchase an aggregate of 550,000 shares of the Company’s common stock.

iZafe Group AB - hereby announces that Zafe Care Systems is ordering 50 Dosell and is now initiating offensive marketing activities to bring the pharmaceutical robot to market.

The ASH Research Collaborative (ASH RC), a non-profit organization established in 2018 by the American Society of Hematology (ASH), and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that GBT will provide a grant of $400,000 to the ASH RC in support of the ASH RC Data Hub Sickle Cell Disease (SCD) program.